Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.
Financial Results:
CG Power & Industrial Solutions Ltd reported Revenues for Q3FY24 of ₹1,979.00 Crores up from ₹1,752.00 Crore year on year, a rise of 12.96%.
Total Expenses for Q3FY24 of ₹1,743.00 Crores up from ₹1,502.00 Crores year on year, a rise of 16.05%.
Consolidated Net Profit of ₹748.00 Crores up 228.07% from ₹228.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.89, up 228.19% from ₹1.49 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.